HOME PRACTICE AREAS ABOUT US CONTACT US STATE RESOURCES CASE REVIEW
  VIDEO LIBRARY   TODAY'S LEGAL HEADLINES   LEGAL DICTIONARY   testimonials   STATUTE OF LIMITATIONS  
 
Areas of Practice
Contact Us
 

Fen-Phen

In 1997 the FDA asked American Home Products (AHP), the makers of Pondimin (Fenfluramine) and Redux (Dexfenfluramine), to withdraw it's popular anti-obesity combination Fen-Phen drug from the market. AHP manufactured fenfluramine under the brand name Pondimin and AHP's subsidiary, Wyeth-Ayerst Laboratories, manufactured dexfenfluramine under the name Redux. Medical studies have linked Pondimin and Redux to heart valve disease...MORE >>


Related Information
Links and Resources
View Complete List >>

Featured Articles on Fen-Phen
Browse Books About Fen-Phen Drug Litigation


1.Dispensing With the Truth : The Victims,...

2.Serotonin : How to Naturally Harness the...

3.Beyond Phen-Fen: The Secrets to Modern,...

4.Mealey's Fen-Phen Trial Strategies...

5.Personal Injury and Product Liability...

6.Psychology in Product Liability and...





The above is not legal advice. That can only come from a qualified attorney who is familiar with all the facts and circumstances of a particular, specific case and the relevant law. See Terms of Use.

 
Copyright 2008 | Home | Contact 404-526-8866